Compare ALTI & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALTI | SOPH |
|---|---|---|
| Founded | 2020 | 2011 |
| Country | United States | Switzerland |
| Employees | 490 | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.2M | 367.7M |
| IPO Year | 2021 | 2021 |
| Metric | ALTI | SOPH |
|---|---|---|
| Price | $3.76 | $5.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | ★ 138.4K | 85.1K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $254,956,000.00 | N/A |
| Revenue This Year | $18.06 | $23.09 |
| Revenue Next Year | $10.71 | $19.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.21 | N/A |
| 52 Week Low | $2.96 | $2.58 |
| 52 Week High | $5.45 | $5.70 |
| Indicator | ALTI | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.90 | 58.63 |
| Support Level | $3.76 | $4.54 |
| Resistance Level | $3.95 | $5.30 |
| Average True Range (ATR) | 0.21 | 0.29 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 69.33 | 71.23 |
AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.